← Back to headlines
Canada Approves Public Reimbursement for Early Alzheimer’s Drug Leqembi
Canada’s national drug agency has issued a final positive recommendation supporting public funding for lecanemab, a treatment for early-stage Alzheimer’s disease.
31 Aug, 23:30 — 31 Aug, 23:30
